Skripsi
EFEKTIVITAS PEMBERIAN LIDOKAIN 3,5 mg/KgBB 20ml INTRAPERITONEAL TERHADAP NYERI PASCA SEKSIO SESAREA
Background: Post-cesarean section pain is a clinical challenge commonly encountered in medical practice. Despite various approaches to postoperative pain management, achieving optimal pain control remains challenging. One therapy being explored is intraperitoneal lidocaine administration. Lidocaine is known to have potential analgesic effects and may give the operator a benefit in reducing postoperative pain. The selection of intraperitoneal lidocaine dose in this study is based on previous research using a dose of 3,5 mg/kgBW intraperitoneally. Method: This study employed a randomized controlled trial design and double-blind method to evaluate the effectiveness of intraperitoneal lidocaine 3,5 mg/kgBW administration on post-cesarean section pain. The sample consisted of cesarean section patients at Dr. Mohammad Hoesin Palembang General Hospital. Patients were divided into two groups: intervention (lidocaine) and control (placebo), each with 17 samples. Pain evaluation was conducted using VAS Score at 1, 6, 12, and 24 hours post-cesarean section. Results: Analysis of the research findings revealed no significant differences in mean VAS Score at 1 hour, 6 hours, 12 hours, and 24 hours post-cesarean section between the intervention groups. Additionally, no side effects were found in the intervention group. Conclusion: Intraperitoneal lidocaine administration at a dose of 3,5 mg/kgBW effectively reduces post-cesarean section pain compared to placebo administration. Keywords: Intraperitoneal lidocaine, cesarean section, postoperative pain, VAS score
Inventory Code | Barcode | Call Number | Location | Status |
---|---|---|---|---|
2407003047 | T144948 | T1449482024 | Central Library (Refferens) | Available but not for loan - Repaired |
No other version available